Information Provided By: 
Fly News Breaks for February 13, 2017
CC
Feb 13, 2017 | 13:03 EDT
Goldman Sachs analyst Robert Koort upgraded Chemours to Buy from Neutral saying the PFOA multi-district litigation settlement "removes a meaningful overhang" on the shares. The resolution should expand "dramatically" the potential investor base that may have been interested in playing a recovering TiO2 market, Koort tells investors in a research note. He views Chemours as "clear industry leader" and upped his price target for the shares to $40 from $27. The stock in afternoon trading is up 14%, or $3.92, to $32.05.
News For CC From the Last 2 Days
There are no results for your query CC
